Results 251 to 260 of about 163,414 (302)

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1927-1940, 1 April 2026.
What's new? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan   +14 more
wiley   +1 more source

Gallbladder and gastric metastasis as initial presentation of an undiagnosed primary lobular breast carcinoma. [PDF]

open access: yesOxf Med Case Reports
Krsteska B   +6 more
europepmc   +1 more source

Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial. [PDF]

open access: yesAnn Surg Oncol
Holmes DR   +13 more
europepmc   +1 more source

Ductal Carcinoma in Situ of the Breast

Annals of Internal Medicine, 1997
The increasing incidence and biological heterogeneity of ductal carcinoma in situ (DCIS) of the breast have made the management of this entity challenging and controversial. This paper reviews data on the natural history of the disease and results obtained with various management approaches.Computerized MEDLINE search of articles related to DCIS ...
R, Fonseca   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy